Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study will be to assess the gastrointestinal effects of a dietary fiber in healthy, adult volunteers.
The study is a blinded, cross-over design with subjects completing three, two-week treatment periods, separated by two, two-week washouts. Volunteers will consume a dietary fiber for two of the treatment periods at two dose levels. The fiber will be added to foods and dispensed to subjects to be consumed twice a day during each treatment period. During the control period, subjects will receive the same study foods, but with no added fiber. Major outcomes will include fecal weight, and responses to questionnaires that assess fecal characteristics, bowel habits and gastrointestinal tolerability.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dietary Fiber - Dose 1 | Experimental | Dietary fiber will be added to study foods |
|
| Dietary Fiber - Dose 2 | Experimental | Dietary fiber will be added to study foods |
|
| Control | Active Comparator | Study foods with no added fiber will be given |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dietary fiber | Other | A proprietary fiber will be given to subjects |
|
| Measure | Description | Time Frame |
|---|---|---|
| Gastrointestinal tolerability | Questionnaire to assess symptoms such as nausea, bloating, and flatulence | subjects will report weekly for 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal output | Fecal weight and stool characteristics will be measured | subjects will collect fecal output for 12 days within a six-week period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kevin Maki, PhD | Provident Clinical Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Provident Clinical Research and Consulting Inc | Glen Ellyn | Illinois | 60137 | United States |
Not provided
| ID | Term |
|---|---|
| D004043 | Dietary Fiber |
| ID | Term |
|---|---|
| D004040 | Dietary Carbohydrates |
| D002241 | Carbohydrates |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D010829 |
| Physiological Phenomena |
| D019602 | Food and Beverages |